Literature DB >> 3762216

An inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine(H-7) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemic cell.

M Ido, T Asao, M Sakurai, M Inagaki, M Saito, H Hidaka.   

Abstract

The effects of protein kinase C inhibitor H-7 (1-(5-isoquinolinylsulfonyl)-2-methylpiperazine) on tumor-promoting phorbol ester induced inhibition of vincristine uptake in P388 murine leukemic cells were investigated with the objective of assessing the possible role of Ca2+-activated, phospholipid-dependent protein kinase (protein kinase C) in vincristine uptake. 12-O-Tetradecanoylphorbol-13-acetate (TPA) is a potent inhibitor at concentrations above 1 nM. Other phorbol esters also inhibited vincristine uptake in approximate proportion to their activity in competing for [20-3H]phorbol 12,13-dibutrate binding. TPA enhanced the Ca2+-activated, phospholipid-dependent phosphorylation of histone III-S by a soluble protein fraction of cells. Phosphorylation of various cell lysate proteins (p18, p21, p29, p34 and p45) were also stimulated by TPA. These TPA-induced stimulations were also inhibited dose-dependently by H-7. It is tentatively concluded that the phosphorylation of cell lysate protein substrates by protein kinase C may be an important mechanism linked to the regulation of vincristine uptake in leukemic cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762216     DOI: 10.1016/0145-2126(86)90050-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

Review 1.  Molecular pharmacology of protein kinases.

Authors:  H Hidaka; M Hagiwara; T Chijiwa
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

2.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 3.  Regulation of protein kinase C and role in cancer biology.

Authors:  G C Blobe; L M Obeid; Y A Hannun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

4.  Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a, and its mechanism of action.

Authors:  S Akinaga; T Ashizawa; K Gomi; H Ohno; M Morimoto; C Murakata; M Okabe
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 5.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Phorbol esters induce multidrug resistance in human breast cancer cells.

Authors:  R L Fine; J Patel; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

7.  Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells.

Authors:  S Citi
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

8.  Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells.

Authors:  M Ido; Y Nagao; M Higashigawa; T Shibata; K Taniguchi; M Hamazaki; M Sakurai
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.